Ledger.Open graph →
SEC Form D · Amendment · filed October 23, 2019

Eliem Therapeutics, Inc

Offering
$16.3M
Sold
$16.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Simon Tate · Cambridge, United KingdomDirectorAndrew Levin · Boston, MAExec · DirectorValerie Morisset · Boston, MAExecDavid-Alexandre Gros · Ranchero Santa Fe, CADirectorJames R. Sechrist · NEWPORT BEACH, CADirectorEdelweiss, LLC · SAN ANTONIO, TXDirectorManish Kshatriya · TORONTO, Ontario, CanadaExecAdam Rossman · TORONTO, Ontario, CanadaExec · DirectorStephen L. Block · Los Angeles, CADirectorSteven T. Cornell · Salisbury, CTDirectorSamuel P. Frieder · MOUNT KISCO, NYExecTheresa L. Sirset · Dublin, OHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗